You are here

Forgács Lajos

Forgács Lajos

Forgács Lajos
Name: Forgács Lajos

Publication list

Uploaded publications:
15
Publications in DEA:
15
OA:
9
Date range:
2019-2023
2023
  1. Adnan, A., Borman, A., Tóth, Z., Forgács, L., Kovács, R., Balázsi, D., Balázs, B., Udvarhelyi, G., Kardos, G., Majoros, L.: In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades.
    Pharmaceutics. 15 (5), 1-16, 2023.
    Journal metrics:
    Q1 Pharmaceutical Science (2022)
  2. Tóth, Z., Bozó, A., Kovács, R., Balogh, B., Balázs, B., Forgács, L., Kelentey, B., Majoros, L.: The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
    Mycopathologia. 188 (1-2), 111-118, 2023.
    Journal metrics:
    Q1 Agronomy and Crop Science (2022)
    Q2 Applied Microbiology and Biotechnology (2022)
    Q2 Microbiology (2022)
    Q1 Plant Science (2022)
    D1 Veterinary (miscellaneous) (2022)
  3. Balla, N., Jakab, Á., Kovács, F., Ragyák, Á., Tóth, Z., Balázsi, D., Forgács, L., Bozó, A., Al Refai, F., Borman, A., Majoros, L., Kovács, R.: Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol.
    AMB Express. 13 (1), 1-10, 2023.
    Journal metrics:
    Q2 Applied Microbiology and Biotechnology (2022)
    Q2 Biophysics (2022)
2022
  1. Forgács, L., Borman, A., Kovács, R., Balázsi, D., Tóth, Z., Balázs, B., Chun-Ju, C., Kardos, G., Kovács, I., Majoros, L.: In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.
    J. Fungi. 8 (5), 1-16, 2022.
    Journal metrics:
    Q1 Ecology, Evolution, Behavior and Systematics
    Q2 Microbiology (medical)
    Q1 Plant Science
2021
  1. Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A., Majoros, L., Kovács, R.: In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
    Med. Mycol. 59 (10), 1015-1023, 2021.
    Journal metrics:
    Q2 Infectious Diseases
    Q2 Medicine (miscellaneous)
    D1 Veterinary (miscellaneous)
  2. Kovács, R., Nagy, F., Tóth, Z., Forgács, L., Tóth, L., Váradi, G., Tóth, G., Vadászi, K., Borman, A., Majoros, L., Galgóczy, L.: The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
    Int. J. Mol. Sci. 22 (2), 1-14, 2021.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    Q1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    Q1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  3. Papp, Z., Borman, A., Forgács, L., Kovács, R., Tóth, Z., Chun-Ju, C., Kardos, G., Juhász, B., Szilvássy, J., Majoros, L.: Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades.
    Pathogens. 10 (8), 1-11, 2021.
    Journal metrics:
    Q2 Immunology and Allergy
    Q2 Immunology and Microbiology (miscellaneous)
    Q2 Infectious Diseases
    Q2 Microbiology (medical)
    Q2 Molecular Biology
2020
  1. Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., Kovács, R.: Candida biofilm production is associated with higher mortality in patients with candidaemia.
    Mycoses. 63 (4), 352-360, 2020.
    Journal metrics:
    Q1 Dermatology
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
  2. Forgács, L., Borman, A., Prépost, E., Tóth, Z., Kardos, G., Kovács, R., Székely, A., Nagy, F., Kovács, I., Majoros, L.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
    Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.
    Journal metrics:
    D1 Drug Discovery
    Q1 Epidemiology
    Q1 Immunology
    D1 Infectious Diseases
    D1 Medicine (miscellaneous)
    Q1 Microbiology
    D1 Parasitology
    Q1 Virology
  3. Nagy, F., Vitális, E., Jakab, Á., Borman, A., Forgács, L., Tóth, Z., Majoros, L., Kovács, R.: In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
    Front. Microbiol. 11 1-12, 2020.
    Journal metrics:
    Q1 Microbiology
    Q1 Microbiology (medical)
2019
updated: 2024-03-17, 01:42

SCImago quartiles of
scientific journal articles

Number of scientific articles: 11
Q1/D1 4 (36.4%)
Q1 8 (72.7%)
Q2 3 (27.3%)
-
OK

SCImago subject areas and categories

Medicine (8)
Infectious Diseases (4)
Medicine (miscellaneous) (4)
Microbiology (medical) (4)
Dermatology (1)
Epidemiology (1)
Immunology and Allergy (1)
Immunology and Microbiology (6)
Microbiology (4)
Applied Microbiology and Biotechnology (2)
Virology (2)
Immunology (1)
Immunology and Microbiology (miscellaneous) (1)
Parasitology (1)
Biochemistry, Genetics and Molecular Biology (3)
Molecular Biology (2)
Biophysics (1)
Agricultural and Biological Sciences (2)
Plant Science (2)
Agronomy and Crop Science (1)
Ecology, Evolution, Behavior and Systematics (1)
Pharmacology, Toxicology and Pharmaceutics (2)
Drug Discovery (1)
Pharmaceutical Science (1)
Veterinary (2)
Veterinary (miscellaneous) (2)
Chemical Engineering (1)
Catalysis (1)
Chemistry (1)
Inorganic Chemistry (1)
Organic Chemistry (1)
Physical and Theoretical Chemistry (1)
Spectroscopy (1)
Computer Science (1)
Computer Science Applications (1)

Genre chart

Year chart

Language chart